356 related articles for article (PubMed ID: 12407648)
1. ACE inhibitors and survival of hemodialysis patients.
Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
[TBL] [Abstract][Full Text] [Related]
2. Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease.
McCullough PA; Sandberg KR; Yee J; Hudson MP
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):188-91. PubMed ID: 12563570
[TBL] [Abstract][Full Text] [Related]
3. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
Hamlett L; Haragsim L
Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
[TBL] [Abstract][Full Text] [Related]
4. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis-associated hypertension: pathophysiology and therapy.
Hörl MP; Hörl WH
Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
[TBL] [Abstract][Full Text] [Related]
6. Disease profile, complications and outcome in patients on maintenance haemodialysis at King Faisal University Hospital, Saudi Arabia.
al-Muhanna FA; Saeed I; al-Muelo S; Larbi E; Rubaish A
East Afr Med J; 1999 Dec; 76(12):664-7. PubMed ID: 10734534
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.
Losito A; Errico R; Santirosi P; Lupattelli T; Scalera GB; Lupattelli L
Nephrol Dial Transplant; 2005 Aug; 20(8):1604-9. PubMed ID: 15870215
[TBL] [Abstract][Full Text] [Related]
10. Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis.
Ondocin PT; Narsipur SS
Nephrology (Carlton); 2006 Dec; 11(6):497-501. PubMed ID: 17199786
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy for hypertension in hemodialysis patients.
Hörl MP; Tepel M
Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
[TBL] [Abstract][Full Text] [Related]
12. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients.
Gowdak LH; Arantes RL; de Paula FJ; Krieger EM; De Lima JJ
Ren Fail; 2007; 29(5):559-65. PubMed ID: 17654318
[TBL] [Abstract][Full Text] [Related]
13. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
[TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
15. Cardiac surgery in patients on chronic hemodialysis: short and long-term survival.
Kogan A; Medalion B; Kornowski R; Raanani E; Sharoni E; Stamler A; Sahar G; Snir E; Porat E
Thorac Cardiovasc Surg; 2008 Apr; 56(3):123-7. PubMed ID: 18365968
[TBL] [Abstract][Full Text] [Related]
16. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
[TBL] [Abstract][Full Text] [Related]
17. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
Mooser V; Fellay G; Regamey C
Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
[TBL] [Abstract][Full Text] [Related]
18. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
[TBL] [Abstract][Full Text] [Related]
20. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
